Advertisement
U.S. Markets closed
S&P Futures
5,885.50 -10.75 (-0.18%) Dow Futures
43,121.00 -56.00 (-0.13%) Nasdaq Futures
20,462.25 -57.25 (-0.28%) Russell 2000 Futures
2,249.50 -6.00 (-0.27%) Crude Oil
70.30 -0.26 (-0.37%) Gold
2,743.40 +4.50 (+0.16%)
Rakovina Therapeutics Inc. (RKV.V)
TSXV - TSXV Real Time Price. Currency in CAD
Follow
At close: 12:53PM EDT
| Previous Close | 0.0800 |
| Open | 0.0850 |
| Bid | 0.0750 x N/A |
| Ask | 0.0800 x N/A |
| Day's Range | 0.0750 - 0.0850 |
| 52 Week Range | 0.0050 - 0.1350 |
| Volume | |
| Avg. Volume | 49,643 |
| Market Cap | 6.772M |
| Beta (5Y Monthly) | 0.05 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings Date | Nov 25, 2024 - Nov 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireRakovina Therapeutics and Variational AI Announce Drug Discovery Collaboration
Companies will jointly research DNA-damage response kinase targets to identify potential drug candidates for the treatment of cancerVANCOUVER, British Columbia, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies and Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, announced today a research colla
- MT Newswires
Rakovina Therapeutics Second-Quarter Loss Widens on Higher Spending
Rakovina Therapeutics Second-Quarter Loss Widens on Higher Spending
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.